Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln
May 8 (Reuters) - Corline Biomedical AB CLBIO.ST: Q1 2026 NET SALES AMOUNT TO 4,291 KSEK Q1 2026 RESULT AFTER FINANCIAL ITEMS AT -2,501 KSEK Source text: ID:nGNEbqj4yH Further company coverage: CLBIO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln